Compare TMDX & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | ATEX |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2019 | 2014 |
| Metric | TMDX | ATEX |
|---|---|---|
| Price | $73.64 | $93.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $148.22 | $50.00 |
| AVG Volume (30 Days) | ★ 969.8K | 451.4K |
| Earning Date | 05-05-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 382.18 | ★ 891.80 |
| EPS | 0.20 | ★ 4.83 |
| Revenue | ★ $605,494,000.00 | $6,501,000.00 |
| Revenue This Year | $24.25 | $2.70 |
| Revenue Next Year | $18.75 | $10.04 |
| P/E Ratio | $355.65 | ★ $20.79 |
| Revenue Growth | ★ 37.13 | 7.79 |
| 52 Week Low | $60.11 | $17.58 |
| 52 Week High | $156.00 | $113.00 |
| Indicator | TMDX | ATEX |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 50.65 |
| Support Level | $64.87 | $91.00 |
| Resistance Level | $79.60 | $111.90 |
| Average True Range (ATR) | 3.13 | 7.35 |
| MACD | 0.02 | -1.94 |
| Stochastic Oscillator | 34.57 | 19.34 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.